Effectiveness and safety of nab-paclitaxel and platinum as first-line chemotherapy for ovarian cancer: a retrospective study

Author:

Wang Liangliang1ORCID,Li Shuangying1ORCID,Zhu Da1ORCID,Qin Yu1ORCID,Wang Xiaoli1ORCID,Hong Zhenya2ORCID,Han Zhiqiang1ORCID

Affiliation:

1. Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

2. Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Funder

National Natural Science Foundation of China

Publisher

XMLink

Subject

Obstetrics and Gynecology,Oncology,General Medicine

Reference40 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Ovarian cancer, including fallopian tube cancer and primary peritoneal cancer (version 1.2022) [Internet]. Plymouth Meeting, PA. National Comprehensive Cancer Network. 2022. cited 2022 Dec 1. Available from: https://www.nccn.org/patients/guidelines/content/PDF/ovarian-patient.pdf

3. A Difference in the Incidences of Hypersensitivity Reactions to Original and Generic Taxanes

4. Pharmacological Effects of Formulation Vehicles

5. Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3